Lately, we don't have to look far for doomsday news or potential policies that make us feel like a dystopian future will soon be our reality. Although we like to joke about it, we've seen pop culture ...

EU mid-market update: All eyes on Fed Chair Powell two-day testimony in Senate; Europe trades sideways with Kering reported ...

The settlement in U.S. v. Gilead could disturb the model of public-private partnership that sustains many of the United ...

Gilead Sciences is rated a Strong Buy due to strong Q4 2024 results and a robust HIV franchise. Check out my 12-month price ...

Piper Sandler analyst Joseph Catanzaro increased the price target on Gilead Sciences stock (NASDAQ:GILD) to $110 from $105, while maintaining an Overweight rating. According to InvestingPro data, the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Writer-director Huo Meng’s Berlin competition entry follows an extended family of farmers scraping by as their country ...

Pres. Trump's proposal for the U.S. to take over Gaza is being denounced by the directors of 'No Other Land,' the ...

What the Bible and history tell us about the claim that God gave the land of Israel to Abraham and his descendants.

“ No Other Land ,” the Palestinian-Israeli Oscar-nominated documentary, has secured a U.K. broadcast deal with Channel 4. The ...

With the FDA approval of Gilead's seladelpar, there have now been two in a matter of weeks. The US agency has cleared seladelpar under the Livdelzi brand name as a second-line therapy for PBC in ...